US health-care costs

Women's Musculoskeletal Health: Insights from the 2024 National Academies of Sciences, Engineering, and Medicine Report on Chronic Conditions.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Rapid Preparation of Electrocompetent Listeria monocytogenes and Enhancement of Transformation Efficiency with cAMP Supplementation.

Journal of food protection·2026

<b>"</b>Anything that would help is a positive development": feasibility, tolerability, and user experience of smartphone-based digital phenotyping for people with and without type 2 diabetes.

BMC digital health·2024

"Do probiotics mitigate GI-induced inflammation and perceived fatigue in athletes? A systematic review".

Journal of the International Society of Sports Nutrition·2024

Direct observation of ultrafast exciton localization in an organic semiconductor with soft X-ray transient absorption spectroscopy.

Nature communications·2022

Toward indicators of the performance of US Infrastructures under climate change risks.

Climatic change·2021

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Health economics review·2026

Fever of unknown origin: cost of illness study.

Open medicine (Warsaw, Poland)·2026

The potential usefulness of health asset valuation to promote health among Korean employees.

Scientific reports·2026

Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation Patients at Very High Risk of Stroke: A Budget Impact Analysis in Italy.

Journal of clinical medicine·2026

Hospitalization costs and out-of-pocket expenses for stroke patients in mainland China.

BMC health services research·2026

[Economic evaluation in the health sector: The link between economic and health variables].

Revista medica del Instituto Mexicano del Seguro Social·2026

Related Experiment Videos

US health-care costs

Related Concept Videos

Women's Musculoskeletal Health: Insights from the 2024 National Academies of Sciences, Engineering, and Medicine Report on Chronic Conditions.

Rapid Preparation of Electrocompetent Listeria monocytogenes and Enhancement of Transformation Efficiency with cAMP Supplementation.

<b>"</b>Anything that would help is a positive development": feasibility, tolerability, and user experience of smartphone-based digital phenotyping for people with and without type 2 diabetes.

"Do probiotics mitigate GI-induced inflammation and perceived fatigue in athletes? A systematic review".

Direct observation of ultrafast exciton localization in an organic semiconductor with soft X-ray transient absorption spectroscopy.

Toward indicators of the performance of US Infrastructures under climate change risks.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Fever of unknown origin: cost of illness study.

The potential usefulness of health asset valuation to promote health among Korean employees.

Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation Patients at Very High Risk of Stroke: A Budget Impact Analysis in Italy.

Hospitalization costs and out-of-pocket expenses for stroke patients in mainland China.

[Economic evaluation in the health sector: The link between economic and health variables].

Related Experiment Videos

US health-care costs

Related Concept Videos

Related Articles